{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T18:16:51Z","timestamp":1786990611037,"version":"build-2736575974"},"reference-count":34,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,9,9]],"date-time":"2022-09-09T00:00:00Z","timestamp":1662681600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100005027","name":"Belgisch Ontwikkelingsagentschap","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005027","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100018370","name":"Prince Leopold Institute of Tropical Medicine","doi-asserted-by":"publisher","award":["0 410 057 701"],"award-info":[{"award-number":["0 410 057 701"]}],"id":[{"id":"10.13039\/100018370","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ijidonline.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Infectious Diseases"],"published-print":{"date-parts":[[2022,11]]},"DOI":"10.1016\/j.ijid.2022.09.012","type":"journal-article","created":{"date-parts":[[2022,9,13]],"date-time":"2022-09-13T04:47:39Z","timestamp":1663044459000},"page":"81-88","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Programmatic management of rifampicin-resistant tuberculosis with standard regimen in Cameroon: a retrospective cohort study"],"prefix":"10.1016","volume":"124","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2591-8438","authenticated-orcid":false,"given":"Christelle G\u00e9nevi\u00e8ve","family":"Jouego","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5518-9600","authenticated-orcid":false,"given":"Tinne","family":"Gils","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6937-3126","authenticated-orcid":false,"given":"Alberto","family":"Piubello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincent","family":"Mbassa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Albert","family":"Kuate","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annie","family":"Ngono","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edwige","family":"Belinga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antoine","family":"Etoundi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alphonse","family":"Tollo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danielle","family":"Makondi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emmanuel","family":"Andr\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2341-6813","authenticated-orcid":false,"given":"Palmer","family":"Masumbe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7183-4895","authenticated-orcid":false,"given":"Lutgarde","family":"Lynen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7656-5070","authenticated-orcid":false,"given":"J\u00fcrgen","family":"Noeske","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1205-1484","authenticated-orcid":false,"given":"Tom","family":"Decroo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijid.2022.09.012_bib0001","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pone.0132394","article-title":"Early mortality during initial treatment of tuberculosis in patients co-infected with HIV at the Yaound\u00e9 Central Hospital, Cameroon: An 8-year retrospective cohort study (2006-2013)","volume":"10","author":"Bigna","year":"2015","journal-title":"PLoS ONE"},{"key":"10.1016\/j.ijid.2022.09.012_bib0002","doi-asserted-by":"crossref","first-page":"S103","DOI":"10.1093\/cid\/cix1138","article-title":"The Persistent Challenge of Advanced HIV Disease and AIDS in the Era of Antiretroviral Therapy","volume":"66","author":"Calmy","year":"2018","journal-title":"Clinical Infectious Diseases"},{"key":"10.1016\/j.ijid.2022.09.012_bib0003","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/jcm9061873","article-title":"Course of adverse events during short treatment regimen in patients with rifampicin-resistant tuberculosis in burundi","volume":"9","author":"Ciza","year":"2020","journal-title":"Journal of Clinical Medicine"},{"key":"10.1016\/j.ijid.2022.09.012_bib0004","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1056\/NEJMoa1901814","article-title":"Treatment of Highly Drug-Resistant Pulmonary Tuberculosis","volume":"382","author":"Conradie","year":"2020","journal-title":"New England Journal of Medicine"},{"key":"10.1016\/j.ijid.2022.09.012_bib0005","volume":"2","author":"Core Development Team R","year":"2020"},{"key":"10.1016\/j.ijid.2022.09.012_bib0006","article-title":"Bedaquiline can act as core drug in a standardized treatment regimen for fluoroquinolone-resistant rifampicin-resistant tuberculosis","author":"Decroo","year":"2021","journal-title":"European Respiratory Journal"},{"key":"10.1016\/j.ijid.2022.09.012_bib0007","doi-asserted-by":"crossref","unstructured":"Decroo T, de Jong BC, Piubello A, Lynen L, Van Deun A. Tuberculosis treatment: one-shot approach or cascade of regimens? 2020a. 10.1016\/S2213-2600(19)30473-4.","DOI":"10.1016\/S2213-2600(19)30473-4"},{"key":"10.1016\/j.ijid.2022.09.012_bib0008","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0238016","article-title":"Injectables\u2019 key role in rifampicin-resistant tuberculosis shorter treatment regimen outcomes","volume":"15","author":"Decroo","year":"2020","journal-title":"PLoS ONE"},{"key":"10.1016\/j.ijid.2022.09.012_bib0009","doi-asserted-by":"crossref","first-page":"239","DOI":"10.5588\/ijtld.17.0660","article-title":"Principles for constructing a tuberculosis treatment regimen: The role and definition of core and companion drugs","volume":"22","author":"Van Deun","year":"2018","journal-title":"International Journal of Tuberculosis and Lung Disease"},{"key":"10.1016\/j.ijid.2022.09.012_bib0010","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1164\/rccm.201001-0077OC","article-title":"Short, highly effective, and inexpensive standardized treatment of multidrug-resistant tuberculosis","volume":"182","author":"Van Deun","year":"2010","journal-title":"American Journal of Respiratory and Critical Care Medicine"},{"key":"10.1016\/j.ijid.2022.09.012_bib0011","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0261149","article-title":"Incidence and predictors of mortality among persons receiving second-line tuberculosis treatment in sub-Saharan Africa: A meta-analysis of 43 cohort studies","volume":"16","author":"Edessa","year":"2021","journal-title":"Plos One"},{"key":"10.1016\/j.ijid.2022.09.012_bib0012","doi-asserted-by":"crossref","first-page":"51521","DOI":"10.1136\/bmjopen-2021-051521","article-title":"Cost-effectiveness of bedaquiline, pretomanid and linezolid for treatment of extensively drug-resistant tuberculosis in South Africa, Georgia and the Philippines","volume":"11","author":"Gomez","year":"2021","journal-title":"BMJ Open"},{"key":"10.1016\/j.ijid.2022.09.012_bib0013","article-title":"Assessment of epidemiological and genetic characteristics and clinical outcomes of resistance to bedaquiline in patients treated for rifampicin-resistant tuberculosis: a cross-sectional and longitudinal study","author":"Ismail","year":"2021","journal-title":"The Lancet Infectious Diseases"},{"key":"10.1016\/j.ijid.2022.09.012_bib0014","first-page":"1","article-title":"Early Mortality in New Patients on Treatment for Smear Positive Pulmonary Tuberculosis in Yaounde-Cameroon","volume":"12","author":"Kuaban","year":"2008","journal-title":"Health Science Diseases"},{"key":"10.1016\/j.ijid.2022.09.012_bib0015","doi-asserted-by":"crossref","first-page":"524","DOI":"10.3201\/eid2403.171362","article-title":"Acquired resistance to antituberculosis drugs in England, wales, and Northern Ireland, 2000\u20132015","volume":"24","author":"Loutet","year":"2018","journal-title":"Emerging Infectious Diseases"},{"key":"10.1016\/j.ijid.2022.09.012_bib0016","unstructured":"Ministry of public health Republic of Cameroon. Programme national de lutte contre la tuberculose: Guide de prise en charge de la tuberculose chez l'enfant. 2020th ed. 2004."},{"key":"10.1016\/j.ijid.2022.09.012_bib0017","doi-asserted-by":"crossref","first-page":"e514","DOI":"10.1016\/S2352-3018(20)30101-6","article-title":"Framework for the implementation of advanced HIV disease diagnostics in sub-Saharan Africa: programmatic perspectives","volume":"7","author":"Ndlovu","year":"2020","journal-title":"The Lancet HIV"},{"key":"10.1016\/j.ijid.2022.09.012_bib0018","doi-asserted-by":"crossref","first-page":"329","DOI":"10.5588\/ijtld.19.0298","article-title":"Reduction of diagnostic and treatment delays reduces rifampicin-resistant tuberculosis mortality in Rwanda","volume":"24","author":"Ngabonziza","year":"2020","journal-title":"International Journal of Tuberculosis and Lung Disease"},{"key":"10.1016\/j.ijid.2022.09.012_bib0019","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.02383-2019","article-title":"Bedaquiline resistance in drug-resistant tuberculosis HIV co-infected patients","volume":"55","author":"Nimmo","year":"2020","journal-title":"European Respiratory Journal"},{"key":"10.1016\/j.ijid.2022.09.012_bib0020","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1056\/NEJMoa1811867","article-title":"A Trial of a Shorter Regimen for Rifampin-Resistant Tuberculosis","author":"Nunn","year":"2019","journal-title":"New England Journal of Medicine"},{"key":"10.1016\/j.ijid.2022.09.012_bib0021","volume":"September","author":"Piubello","year":"2018"},{"key":"10.1016\/j.ijid.2022.09.012_bib0022","doi-asserted-by":"crossref","DOI":"10.1016\/j.rmed.2019.105844","article-title":"Management of multidrug-resistant tuberculosis with shorter treatment regimen in Niger: Nationwide programmatic achievements","volume":"161","author":"Piubello","year":"2020","journal-title":"Respiratory Medicine"},{"key":"10.1016\/j.ijid.2022.09.012_bib0023","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-019-48289-9","article-title":"Fluoroquinolone heteroresistance in Mycobacterium tuberculosis: detection by genotypic and phenotypic assays in experimentally mixed populations","volume":"9","author":"Rigouts","year":"2019","journal-title":"Scientific Reports"},{"key":"10.1016\/j.ijid.2022.09.012_bib0024","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.02250-2020","article-title":"High rifampicin-resistant TB cure rates and prevention of severe ototoxicity after replacing the injectable by linezolid in early stage of hearing loss","volume":"57","author":"Souleymane","year":"2021","journal-title":"European Respiratory Journal"},{"key":"10.1016\/j.ijid.2022.09.012_bib0025","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1093\/jac\/dkaa489","article-title":"Second-line injectable drugs for rifampicin-resistant tuberculosis: Better the devil we know?","volume":"76","author":"Tahseen","year":"2021","journal-title":"Journal of Antimicrobial Chemotherapy"},{"key":"10.1016\/j.ijid.2022.09.012_bib0026","doi-asserted-by":"crossref","first-page":"55","DOI":"10.3390\/jcm9010055","article-title":"Short-course regimen for multidrug-resistant tuberculosis: A decade of evidence","volume":"9","author":"Tr\u00e9bucq","year":"2020","journal-title":"Journal of Clinical Medicine"},{"key":"10.1016\/j.ijid.2022.09.012_bib0027","doi-asserted-by":"crossref","first-page":"17","DOI":"10.5588\/ijtld.17.0498","article-title":"Treatment outcome with a short multidrug-resistant tuberculosis regimen in nine African countries","volume":"22","author":"Trebucq","year":"2018","journal-title":"International Journal of Tuberculosis and Lung Disease"},{"key":"10.1016\/j.ijid.2022.09.012_bib0028","series-title":"Consolidated guidelines on tuberculosis. Module 4: treatment - drug-resistant tuberculosis treatment","year":"2020"},{"key":"10.1016\/j.ijid.2022.09.012_bib0029","series-title":"Rapid Communication: Key changes to the treatment of drug-resistant tuberculosis","first-page":"6","year":"2022"},{"key":"10.1016\/j.ijid.2022.09.012_bib0030","volume":"4","year":"2020"},{"key":"10.1016\/j.ijid.2022.09.012_bib0031","unstructured":"World Health Organization (WHO). Guidelines for managing advanced HIV disease and rapid initiation of antiretroviral therapy. 2017."},{"key":"10.1016\/j.ijid.2022.09.012_bib0032","unstructured":"World Health Organization (WHO). Companion Handbook to the WHO Guidelines for the Programmatic Management of Drug-Resistant Tuberculosis. 20 Avenue Appia, 1211 Geneva 27, Switzerland: 2014a."},{"key":"10.1016\/j.ijid.2022.09.012_bib0033","unstructured":"World Health Organization (WHO). Definitions and reporting framework for tuberculosis \u20132013 revision. WHO\/HTM\/TB. 20 Avenue Appia, 1211 Geneva 27, Switzerland: 2014b."},{"key":"10.1016\/j.ijid.2022.09.012_bib0034","article-title":"Epidemiology of antituberculosis drug resistance 2002-07: an updated analysis of the Global Project on Anti-Tuberculosis Drug Resistance Surveillance","volume":"373","author":"Wright","year":"2009","journal-title":"WwwThelancetCom"}],"container-title":["International Journal of Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1201971222005112?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1201971222005112?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T08:09:54Z","timestamp":1761120594000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1201971222005112"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11]]},"references-count":34,"alternative-id":["S1201971222005112"],"URL":"https:\/\/doi.org\/10.1016\/j.ijid.2022.09.012","relation":{},"ISSN":["1201-9712"],"issn-type":[{"value":"1201-9712","type":"print"}],"subject":[],"published":{"date-parts":[[2022,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Programmatic management of rifampicin-resistant tuberculosis with standard regimen in Cameroon: a retrospective cohort study","name":"articletitle","label":"Article Title"},{"value":"International Journal of Infectious Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijid.2022.09.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Author(s). Published by Elsevier Ltd on behalf of International Society for Infectious Diseases.","name":"copyright","label":"Copyright"}]}}